NORMAN SCHWARTZ - 03 Mar 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIO.B)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Issuer symbol
BIO BIO.B
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
05 Mar 2025, 17:03:00 UTC
Previous filing
10 Sep 2024
Next filing
03 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO BIO.B Bio-Rad A Common Stock 438,238 03 Mar 2025 Direct
holding BIO BIO.B Bio-Rad B Common Stock 361,466 03 Mar 2025 Direct
holding BIO BIO.B Bio-Rad B Common Stock 13,006 03 Mar 2025 By Spouse F1
holding BIO BIO.B Bio-Rad B Common Stock 4,060,054 03 Mar 2025 By Blue Raven Partners, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Non-Qualified Stock Option (right to buy) Award $0 +11,671 $0.000000 11,671 03 Mar 2025 Bio-Rad A Common Stock 11,671 $256.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these shares.
F2 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.